Oragenics (OGEN) Change in Receivables (2010 - 2016)
Oragenics' (OGEN) quarterly Change in Receivables came in at $11633.0 in Q1 2016, down 16.63% YoY from $13953.0 in Q2 2015, and up 565.5% on a QoQ basis from $1748.0 in Q4 2015.
Oragenics (OGEN) Change in Receivables (2010 - 2016) Analysis & Trends
Oragenics (OGEN) has 7 years of Change in Receivables data on file, last reported at $11633.0 in Q1 2016.
- Quarterly Change in Receivables fell 16.63% year-over-year to $11633.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $3187.0 (up 123.92% YoY) and the FY2015 annual result came in at $5507.0, up 111.28% from the prior year.
- Change in Receivables rose to $11633.0 in Q1 2016, from $1748.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $32957.0 in Q3 2012 to a low of -$29330.0 in Q1 2012.
- A 5-year average of -$3523.3 and a median of -$2763.0 in 2015 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2012 — Change in Receivables surged 406.43% — and 2015, when it plunged 313.29%.
- Tracing OGEN's Change in Receivables over 5 years: stood at -$2584.0 in 2012, then soared by 315.02% to $5556.0 in 2013, then plunged by 292.6% to -$10701.0 in 2014, then surged by 116.33% to $1748.0 in 2015, then surged by 565.5% to $11633.0 in 2016.
- The last three Change in Receivables figures came in at $11633.0 (Q1 2016), $1748.0 (Q4 2015), and -$7431.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Oragenics | 2.32 Mn | 2.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 11,633.00 |
| Mar 31, 2016 | 11,633.00 |
| Dec 31, 2015 | 1,748.00 |
| Dec 31, 2015 | 1,748.00 |
| Sep 30, 2015 | -7,431.00 |
| Sep 30, 2015 | -7,431.00 |
| Jun 30, 2015 | -2,763.00 |
| Jun 30, 2015 | -2,763.00 |
| Mar 31, 2015 | 13,953.00 |
| Mar 31, 2015 | 13,953.00 |
| Dec 31, 2014 | -10,701.00 |
| Dec 31, 2014 | -10,701.00 |
| Sep 30, 2014 | 3,484.00 |
| Sep 30, 2014 | 3,484.00 |
| Jun 30, 2014 | -20,059.00 |
| Jun 30, 2014 | -20,059.00 |
| Mar 31, 2014 | -21,550.00 |
| Mar 31, 2014 | -21,550.00 |
| Dec 31, 2013 | 5,556.00 |
| Dec 31, 2013 | 5,556.00 |